Impact GLP-1 Agonists Following Bariatric | MicrobiomeTrials← Back to trialsNCT06132477
Impact GLP-1 Agonists Following Bariatric
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2024-02-01Est. Completion: 2028-07
Enrollment target: 150 participants Locations- University of Missouri Hospital, Columbia, Missouri, United States
Other microbiome trials you might be interested in
Obesity, MorbidMetabolic SyndromeNASH - Nonalcoholic Steatohepatitis
Variable outcomes after weight loss surgery are likely attributable to complex, poorly understood mechanisms. Due to the…
Columbia, United StatesCompleted Mar 1, 2031
Morbid Obesity Requiring Bariatric SurgeryNeck Pain Musculoskeletal
Obesity may contribute to neck pain, altered cervical posture, and impaired cervical function through increased mechanic…
Istanbul, Turkey (Türkiye)Est. completion Jul 2027
Completed
Skeletal MuscleBariatric Surgery
Metabolic and bariatric surgery produces substantial and durable weight loss, but a considerable proportion of that loss…
Alexandria, EgyptCompleted Jul 17, 2026